Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatokines and metabolism: Deciphering communication from the liver
Sharon O. Jensen-Cody, Matthew J. Potthoff
Molecular Metabolism (2020) Vol. 44, pp. 101138-101138
Open Access | Times Cited: 170

Showing 1-25 of 170 citing articles:

Metabolic Messengers: FGF21
Kyle H. Flippo, Matthew J. Potthoff
Nature Metabolism (2021) Vol. 3, Iss. 3, pp. 309-317
Open Access | Times Cited: 197
Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
Aldona Kasprzak
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6434-6434
Open Access | Times Cited: 143
Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions
Ana Rita de Oliveira dos Santos, Bárbara de Oliveira Zanuso, Vitor Fernando Bordin Miola, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2639-2639
Open Access | Times Cited: 137
The role of hepatokines in NAFLD
Norbert Stefan, Fritz Schick, Andreas L. Birkenfeld, et al.
Cell Metabolism (2023) Vol. 35, Iss. 2, pp. 236-252
Open Access | Times Cited: 137
The molecular pharmacology of glucagon agonists in diabetes and obesity
Aaron Novikoff, Timo D. Müller
Peptides (2023) Vol. 165, pp. 171003-171003
Open Access | Times Cited: 40
Insulin Resistance: The Increased Risk of Cancers
Leszek Szablewski
Current Oncology (2024) Vol. 31, Iss. 2, pp. 998-1027
Open Access | Times Cited: 32
Gut-liver axis calibrates intestinal stem cell fitness
Girak Kim, Zuojia Chen, Jian Li, et al.
Cell (2024) Vol. 187, Iss. 4, pp. 914-930.e20
Open Access | Times Cited: 25
Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases
Reddemma Sandireddy, Suganya Sakthivel, Priyanka Gupta, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 19
Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology
Sara Della Torre
Cells (2021) Vol. 10, Iss. 9, pp. 2502-2502
Open Access | Times Cited: 55
Modelling metabolic diseases and drug response using stem cells and organoids
Wenxiang Hu, Mitchell A. Lazar
Nature Reviews Endocrinology (2022) Vol. 18, Iss. 12, pp. 744-759
Open Access | Times Cited: 55
Extracellular Vesicles-Based Cell-Free Therapy for Liver Regeneration
Mustapha Najimi, Haider Khawaja
(2022), pp. 1-18
Closed Access | Times Cited: 46
Pathogenesis of Dementia
Janusz Błaszczyk
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 543-543
Open Access | Times Cited: 41
A single-nucleus transcriptomic atlas of primate liver aging uncovers the pro-senescence role of SREBP2 in hepatocytes
Shanshan Yang, Chengyu Liu, Mengmeng Jiang, et al.
Protein & Cell (2023) Vol. 15, Iss. 2, pp. 98-120
Open Access | Times Cited: 27
The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease—The Transition from an Adipocentric to Liver-Centric Approach
Milena Vesković, Nikola Šutulović, Dragan Hrnčić, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 9084-9102
Open Access | Times Cited: 27
A biomarker framework for liver aging: the Aging Biomarker Consortium consensus statement
Mengmeng Jiang, Zhuozhao Zheng, Xuan Wang, et al.
Life Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 13
Liver-derived extracellular vesicles improve whole-body glycaemic control via inter-organ communication
Paula M. Miotto, Chieh-Hsin Yang, Stacey N. Keenan, et al.
Nature Metabolism (2024) Vol. 6, Iss. 2, pp. 254-272
Closed Access | Times Cited: 11
Aging promotes metabolic dysfunction-associated steatotic liver disease by inducing ferroptotic stress
Kuo Du, Liuyang Wang, Ji Hye Jun, et al.
Nature Aging (2024) Vol. 4, Iss. 7, pp. 949-968
Closed Access | Times Cited: 10
Sarcopenia in MASLD—Eat to Beat Steatosis, Move to Prove Strength
Dana Crișan, Lucreţia Avram, Andreea Morariu-Barb, et al.
Nutrients (2025) Vol. 17, Iss. 1, pp. 178-178
Open Access | Times Cited: 1
Metabolic dysfunction-associated steatotic liver disease: A sexually dimorphic disease and breast and gynecological cancer
Xinrong Zhang, Mindie H. Nguyen
Metabolism (2025), pp. 156190-156190
Closed Access | Times Cited: 1
A comprehensive review on the phytochemistry, pharmacokinetics, and antidiabetic effect of Ginseng
Yage Liu, Hao Zhang, Xuan Dai, et al.
Phytomedicine (2021) Vol. 92, pp. 153717-153717
Closed Access | Times Cited: 43
NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook
Alberto Nascè, Karim Gariani, François R. Jornayvaz, et al.
Antioxidants (2022) Vol. 11, Iss. 6, pp. 1131-1131
Open Access | Times Cited: 28
The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
Alexandra C Finney, Sandeep R. Das, Dhananjay Kumar, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 21
Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies
Hehua Guo, Jiazheng Sun, Siyu Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Highlights on Future Treatments of IPF: Clues and Pitfalls
Alessandro Libra, Enrico Sciacca, Giuseppe Muscato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8392-8392
Open Access | Times Cited: 7
Nuclear Nicotinamide Adenine Dinucleotide Deficiency by Nmnat1 Deletion Impaired Hepatic Insulin Signaling, Mitochondrial Function, and Hepatokine Expression in Mice Fed a High-Fat Diet
Haibo Dong, Wei Guo, Ruichao Yue, et al.
Laboratory Investigation (2024) Vol. 104, Iss. 3, pp. 100329-100329
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top